Best Supplements to Take With Dihexa

Dihexa Builds New Synapses, and Building Requires Raw Materials

Most cognitive compounds work by adjusting neurotransmitter levels. They keep more dopamine in the synapse, slow the breakdown of acetylcholine, or briefly raise serotonin. When they stop, the levels normalize and the effect ends. Dihexa does something structurally different.

Dihexa is a synthetic heptapeptide, a short chain of seven amino acids, derived from angiotensin IV. Its primary target is not a neurotransmitter receptor or a clearance enzyme. It binds to hepatocyte growth factor, a signaling protein the body already produces, and enhances HGF's ability to activate its receptor on neurons. That receptor is called c-Met, and what its activation triggers is synaptogenesis: the actual physical formation of new dendritic spines and synaptic contacts between neurons. Dendritic spines are the tiny protrusions on a neuron that reach out to form connections with neighboring cells. Synaptogenesis means making more of them. This is structural neuroplasticity, not a transient chemical shift.

The potency is extraordinary even by research-compound standards. Dihexa operates at picomolar concentrations, which means concentrations in the range of one trillionth of a mole per liter. BDNF, the brain's own major driver of synaptic plasticity, operates at nanomolar concentrations and crosses the blood-brain barrier poorly, often requiring direct injection to reach the brain in therapeutic amounts. Dihexa is orally bioavailable, crosses the blood-brain barrier intact, and initiates the same downstream signaling cascade at concentrations that are orders of magnitude lower. The curated sheet notes this plainly, and the note is not marketing language: it is the central fact that shapes this entire supplement guide.

That extraordinary potency is what makes the supporting supplements matter in a particular way. Dihexa is not asking the brain to feel differently for a few hours. It is asking the brain to build something. Building requires substrates. New synaptic membranes are assembled primarily from DHA-rich phospholipids. Cholinergic synapses, those that transmit signals using acetylcholine as the chemical messenger, depend on a steady choline supply. The neurochemical environment in which synaptogenesis proceeds is degraded by elevated homocysteine, a compound cleared by B vitamins, and undermined by the vitamin D and magnesium deficiencies that are common in the adult population.

One important caveat sits at the foundation of all of this. A 2014 paper by Benoist and colleagues, which provided formal biochemical evidence for the HGF/c-Met mechanism, was retracted in April 2025, alongside a 2012 paper by Kawas. This retraction does not erase the animal and observational evidence that Dihexa produces synaptogenic effects. Researchers in the Harding laboratory, where Dihexa was developed, continue to support HGF/c-Met as the operative mechanism, and subsequent work maintains that framing. But the direct biochemical evidence is now disputed rather than settled, and that is an honest characterization of where the science currently stands.

What is not in dispute: Dihexa has no completed human clinical trials. Every claim about its effects in people is anecdotal or extrapolated from animal models. No FDA approval exists. All use is investigational. The supplements in this guide are chosen because they support the neurological environment and construction process that Dihexa appears to drive, grounded in its known mechanism and the biology of synaptogenesis rather than human trial data on the specific pairings.

The Supplements That Matter Most on Dihexa

There are no dose numbers on this page. The right amount of each of these depends on your actual Dihexa protocol, your bloodwork, and what else you are currently taking. Someone with confirmed low ferritin needs a meaningfully different iron approach than someone with normal stores, and the same reasoning applies across the rest of the list. MyPeptidePal works out the specifics from your protocol, your labs, and your inputs.

What the Brain Needs to Actually Build Something

Dihexa initiates a construction process. The supplements in this section provide material that process requires.

Choline (Alpha-GPC or citicoline)

This is the most immediately relevant cofactor on the list, and it earns its place through two distinct biological jobs that both trace back to the same thing Dihexa is doing.

The first job is neurotransmission. A large proportion of the synapses that synaptogenesis produces are cholinergic, meaning they transmit signals using acetylcholine as the chemical messenger. The enzyme that synthesizes acetylcholine, choline acetyltransferase, is choline-limited: it can only produce as much acetylcholine as the available choline supply allows. Build new synapses without enough choline to run them and you have architecture waiting for material.

The second job is membrane construction. Synaptic membranes are composed of phospholipids, and phosphatidylcholine is one of the principal structural components. Every new dendritic spine and every new synaptic contact that Dihexa drives the brain to form needs phosphatidylcholine as a physical building block. Choline is the precursor to that molecule.

Alpha-GPC, which stands for alpha-glycerophosphocholine, is highly bioavailable and crosses the blood-brain barrier efficiently. Citicoline, also called CDP-choline, provides choline alongside cytidine, which the brain converts to uridine, a building block for additional phosphatidylcholine synthesis. Both are legitimate options. The pairing logic with Dihexa is direct and mechanistic, though neither has been tested alongside Dihexa in controlled human research. That is an honest characterization of where the evidence sits for this entire stack.

Omega-3 Fatty Acids (DHA)

DHA, or docosahexaenoic acid, is the dominant omega-3 fatty acid in brain tissue, concentrated particularly in synaptic membranes. This is not coincidental. Membranes built with DHA are more fluid, more flexible, and more capable of the rapid remodeling that synaptogenesis requires. When DHA availability falls, the brain incorporates a shorter and less functionally capable substitute in its place.

The argument for DHA alongside Dihexa follows directly from the structural nature of Dihexa's mechanism. HGF/c-Met activation drives the formation of new dendritic spines and synaptic membranes. That physical construction requires raw material. DHA is the principal material for the membrane component. If Dihexa is the instruction to build, DHA is part of what the building is made of.

DHA also reduces neuroinflammation by supporting the synthesis of specialized signaling molecules that help end inflammatory cascades in the brain. A brain with sustained neuroinflammation is not an optimal environment for synaptogenesis, so this is a genuine secondary benefit rather than a stretch argument.

EPA, the other omega-3 in standard fish oil, primarily supports blood vessel health in the brain, improving oxygen and nutrient delivery to newly active regions. It is worth including alongside DHA rather than pursuing DHA in isolation.

The evidence for DHA in brain membrane health and function comes from clinical nutritional research. The specific pairing with Dihexa is mechanistic reasoning rather than a directly studied application.

Address These Before Blaming the Compound

Three deficiency states are common enough in the adult population, and directly consequential enough for the process Dihexa drives, that correcting them before or alongside the compound is the right sequence.

Iron

Iron is not obviously connected to cognitive performance, but it sits upstream of several processes that Dihexa's synaptogenic work depends on.

Iron is an essential cofactor for tyrosine hydroxylase, the enzyme that catalyzes the first step in synthesizing dopamine. Iron is also required by oligodendrocytes, the cells responsible for producing myelin, the insulating sheath around neurons that governs how quickly and reliably they conduct signals. And hippocampal BDNF, the brain's own major plasticity-promoting protein, is downregulated when iron stores fall. BDNF and Dihexa's HGF/c-Met pathway converge on overlapping downstream plasticity effects, so BDNF suppression from iron deficiency directly undercuts the environment in which Dihexa is operating.

The consequence for a Dihexa protocol is concrete: if iron is low, dopamine synthesis is throttled, myelin maintenance is compromised, and endogenous plasticity signaling is suppressed, all while Dihexa is attempting to drive new synapse formation. Correcting a genuine deficiency removes this upstream obstruction before it limits what Dihexa can accomplish downstream.

Iron deficiency and particularly low ferritin, the stored form of iron that is the most clinically informative marker, is genuinely common in menstruating women and endurance athletes and more prevalent in the broader population than is widely appreciated. This is not a supplement to take speculatively. Check ferritin first. If stores are adequate, there is no case for iron supplementation here, and excess iron is not harmless. If ferritin is low, correcting it is likely more important than any other item on this list.

The evidence for iron deficiency impairing cognition and neuroplasticity is clinical. The specific link to Dihexa's mechanism is reasoning from established biology.

B Vitamins (B12, Folate, B6)

These three B vitamins work as a unit in the methylation cycle, the biochemical pathway that converts homocysteine into methionine and other useful compounds. Homocysteine is a potentially neurotoxic intermediate that accumulates when any one of the three vitamins is insufficient.

The reason homocysteine matters specifically in the context of Dihexa is the nature of what Dihexa is trying to accomplish. Elevated homocysteine causes direct neurotoxicity, damages the cells lining cerebral blood vessels, and promotes a state of low-grade neuroinflammation. This is precisely the cognitive-decline environment that a synaptogenic compound is meant to address. Running Dihexa into a high-homocysteine environment means working against your own goal.

The evidence for B vitamin supplementation lowering homocysteine is among the most robust in the dietary supplement literature, clearly in the clinical category. Elevated homocysteine is also one of the most predictive available blood markers for cognitive decline risk, and correcting it through B vitamins is a well-supported intervention.

B12 and folate carry a second function relevant here: both are required for myelin synthesis. New synapses built through Dihexa's mechanism are useful only if the neurons they connect can transmit signals efficiently. B12 deficiency degrades that infrastructure over time, reducing the functional return on the structural investment Dihexa makes.

The preferred forms matter in practice. Methylcobalamin is the active form of B12 and is generally preferred over cyanocobalamin. Methylfolate is the active form of folate. It is important for the meaningful portion of the population who carry genetic variants that reduce their ability to convert synthetic folic acid into a usable form. If you have been told you have difficulty processing folic acid, methylfolate is the form to use.

Vitamin D

Vitamin D is flagged as a double-duty pick because it works across two distinct support functions simultaneously, and both of them are relevant to this compound specifically.

The first function is indirect but concrete: vitamin D regulates magnesium absorption in the gut. When vitamin D is low, magnesium absorption is impaired even when dietary magnesium intake looks adequate on paper. This creates a paired deficiency where both nutrients are functionally low at the same time, and correcting one without the other produces incomplete results. Given that magnesium is central to both side-effect mitigation and synapse function in this stack, vitamin D becomes a gating nutrient for the magnesium story.

The second function is that vitamin D supports mitochondrial signaling in neurons. Mitochondria are the energy-generating structures inside cells, and neurons are among the most energy-demanding cells in the body. Vitamin D deficiency reduces mitochondrial efficiency, lowering ATP availability in the cells where synaptogenesis is happening. It also correlates inversely with homocysteine levels, meaning that low vitamin D and high homocysteine tend to co-occur, reinforcing the neurotoxic pressure the B vitamins are trying to relieve.

Vitamin D deficiency is common at northern latitudes, in people who work indoors, and across the general adult population during winter months. The blood level threshold associated with optimal neurological function appears to be higher than the threshold used to define clinical deficiency, which is another way of saying that a result that is technically sufficient may still be leaving something on the table.

Vitamin D is fat-soluble, so it needs to be taken with a meal containing fat to absorb properly. Vitamin K2 in the MK-7 form is worth co-administering: it directs the calcium that vitamin D mobilizes to bone rather than allowing it to deposit in soft tissue.

Overstimulation, and What Actually Blunts It

Dihexa's exceptional potency is an asset for the cognitive outcome and a liability for tolerability, particularly early in use. Headaches are the most commonly reported side effect across community protocols. Overstimulation, mood changes, and sleep disruption are also reported with meaningful frequency.

Magnesium

Magnesium is the most practically useful side-effect mitigation on this list, and it earns a double-duty designation because it matters beyond just the side effects.

The direct side-effect role: magnesium is a natural regulator of neuronal excitability. It does this by physically occupying the channel of NMDA receptors when neurons are at rest, preventing them from activating inappropriately. NMDA receptors are a type of glutamate receptor, and glutamate is the brain's primary excitatory neurotransmitter. In the context of a highly potent nootropic driving rapid synaptogenic activity, magnesium's role as a gatekeeper of these receptors gives it a plausible mechanism for reducing the headaches and overstimulation that some users experience. The connection between excess neuronal excitation and headache is well-established, and magnesium deficiency is a recognized contributing factor in headache disorders.

The second role is why magnesium is a double-duty pick. NMDA receptors are also the molecular site where long-term potentiation occurs. Long-term potentiation is the process through which a synapse becomes stronger with repeated use. It is how a newly formed synapse, the kind Dihexa produces, gets converted from a structural possibility into a functionally strong connection. Without adequate magnesium regulating NMDA receptor function, new synapses can exist structurally without being efficiently reinforced through activity.

Magnesium glycinate has a strong tolerability profile and is well-suited to evening dosing, which also addresses the sleep disruption some users report. Magnesium L-threonate is a specialized form developed specifically for brain penetration, engineered to cross the blood-brain barrier more readily than standard magnesium forms. It is worth considering if the NMDA receptor function argument, rather than just the side-effect mitigation, is the priority.

A note on testing: serum magnesium is nearly useless as an indicator of actual magnesium status because the body regulates serum levels tightly at the expense of intracellular stores. RBC magnesium, measured in red blood cells, reflects genuine status.

L-Theanine

L-theanine is an amino acid found naturally in green tea. It promotes alpha-wave activity in the brain, a neurological state associated with relaxed alertness rather than either anxious arousal or sedation. Crucially, it does this without reducing cognitive sharpness.

In community protocols built around potent nootropic compounds, L-theanine is a common pairing because it specifically targets the anxious, overstimulated edge that powerful cognitive compounds can produce, without dulling the output those compounds are intended to generate. The pairing logic with Dihexa is that synaptogenic work creates cognitive opportunity; L-theanine helps that opportunity land in a neurological state that can use it cleanly rather than one driven by overstimulation.

Small randomized controlled trials have examined L-theanine's effect on stress and cognitive state, with generally favorable results for the relaxed-alertness outcome. L-theanine is also well studied in combination with caffeine, and that pairing has stronger published support than L-theanine alone. If caffeine is part of the protocol, the pairing with L-theanine is particularly well-grounded. The application specifically to Dihexa is community practice.

Where Complementary Pathways Add to the Result

Creatine

Creatine is overwhelmingly associated with muscle performance, so its presence in a nootropic stack requires explanation. The mechanism in the brain is the same one that makes it valuable in muscle: it maintains rapid availability of ATP, the molecule cells use as their energy currency, during periods of high metabolic demand.

Synaptogenesis is metabolically expensive. Assembling new dendritic spines, organizing synaptic machinery, maintaining newly formed connections, all of this requires sustained ATP. Creatine, stored in cells as phosphocreatine, provides the fastest available mechanism for resynthesizing ATP when demand spikes above what ordinary metabolism can supply in real time. There is no direct pharmacological interaction between creatine and Dihexa's HGF/c-Met pathway. What creatine provides is the cellular energy foundation that the synaptogenic process benefits from.

Brain creatine levels do rise with oral supplementation, a finding that has emerged from neuroimaging research. The evidence for creatine supporting brain energy and ATP buffering is clinical. The application specifically to Dihexa protocols is a mechanistic extrapolation rather than a studied pairing, which is an accurate description of where the evidence is.

Creatine monohydrate is the form with the most extensive evidence base and is as effective as more expensive formulations.

Lion's Mane

Lion's Mane mushroom, Hericium erinaceus, contains two families of bioactive compounds called hericenones and erinacines. These stimulate the synthesis of NGF, nerve growth factor, a protein that supports the survival, maintenance, and growth of neurons, particularly those in the cholinergic system.

The reason Lion's Mane belongs alongside Dihexa rather than being redundant to it is that it operates through an entirely different receptor system. NGF acts through TrkA, the receptor protein that nerve growth factor binds to on a neuron's surface. Dihexa acts through HGF/c-Met. These are parallel neurotrophin pathways operating independently, not the same signal amplified twice. Running both creates mechanistic diversification: two separate plasticity-promoting inputs through two separate biological routes.

Small human randomized controlled trials have examined Lion's Mane for cognitive function in older adults, with measurable improvements in cognitive test scores in the supplemented groups. Those studies used fruiting body extract. Mycelium-based products, which are more widely available and cheaper, have a different and less well-characterized bioactive content. Fruiting body is the specification that the evidence supports.

There is a caution worth naming directly. Running two simultaneous neuroplasticity-promoting pathways raises a theoretical concern that neurons could become overstimulated at high doses of both. Overstimulation of this kind refers to a state where neurons are driven to the point of dysfunction by excessive excitatory signaling. At standard doses of both Dihexa and Lion's Mane, this remains theoretical rather than reported. It is, however, one of the specific reasons the start-low, one-supplement-at-a-time principle applies with particular force here.

Cautions and Interactions

Active Cancer or Malignancy

This is an absolute contraindication, and it leads this section because it is the one situation where the consequence of proceeding cannot be addressed through dose reduction or monitoring.

Dihexa activates the HGF/c-Met pathway. c-Met is a growth-signaling protein on cell surfaces that promotes cell growth, proliferation, and survival. In healthy neurons, that is the mechanism that makes Dihexa valuable. In tumor cells, c-Met activation promotes tumor growth, invasion into surrounding tissue, and metastasis. The pathway does not distinguish between neuron and cancer cell based on the user's intention. c-Met activation is c-Met activation.

Individuals with an active malignancy should not use Dihexa. Individuals with a cancer diagnosis within the past five years, with precancerous conditions such as Barrett's esophagus or cervical dysplasia, or with significant hereditary cancer risk including BRCA mutations or Lynch syndrome should consult an oncologist before considering any compound that activates this pathway. This is not a precautionary framing that errs toward caution for legal reasons. The biological mechanism is direct, and the consequence in an affected individual would be serious.

St. John's Wort

St. John's Wort is a botanical widely sold over the counter for mood support, and it is one of the most potent activators of the liver enzyme system responsible for metabolizing a broad range of compounds. Activating that enzyme system means accelerating the clearance of anything sharing the same metabolic pathway. For Dihexa, the consequence is faster clearance, lower sustained concentration in the body, and reduced efficacy. Most people do not think of a botanical supplement as something with significant drug interactions. St. John's Wort is the exception, and it is listed here by name because of how commonly it is used without awareness of this effect. Discontinue it before starting Dihexa.

c-Met Inhibitors

Oncology drugs including capmatinib, tepotinib, and crizotinib are prescribed specifically to block c-Met signaling in certain cancers. They are the pharmacological opposite of Dihexa. Taking both simultaneously means one drug is activating the exact pathway the other is designed to suppress. Beyond neutralizing both effects, the concurrent activation and suppression of the same receptor system can produce unpredictable downstream signaling patterns. This is a serious interaction without a workable titration solution.

Prescription Medications and Metabolic Considerations

Several common prescription drug classes interact with Dihexa through the liver enzyme system that handles its metabolism. Strong inhibitors of that system, including certain antifungals, some HIV antiretrovirals, and clarithromycin, slow Dihexa's metabolism and raise its systemic exposure above the intended range. Medications that share this same metabolic pathway, including many statins, some benzodiazepines, and certain antiarrhythmics, can have their own blood levels affected when metabolic capacity is shared or competed for.

ACE inhibitors and angiotensin receptor blockers, blood pressure medications that operate within the renin-angiotensin system from which Dihexa is structurally derived, represent a separate category of concern. They alter the balance of angiotensin-related peptides in ways that may modify the signaling environment Dihexa operates in. The interaction is theoretical, but the shared biological system is real.

Anticoagulants such as warfarin carry a theoretical bleeding risk through HGF's effects on coagulation pathways combined with metabolic competition. Anyone taking warfarin or similar medications should treat this as a serious interaction requiring prescriber involvement.

Anyone taking prescribed medications should discuss Dihexa with their clinician before use. This is not routine boilerplate. It is the appropriate response to a compound with no human safety trial data and metabolic overlap with a wide range of common medications.

Stimulant Medications and Nootropic Combinations

Combining Dihexa with prescription stimulants such as amphetamines or methylphenidate may layer synaptogenic neurochemistry onto stimulant-driven arousal, producing anxiety, mood instability, and sleep disruption. The same principle applies to other potent nootropics. The governing rule is one supplement at a time: do not introduce a new item to this stack until you have fully observed your response to what is already in it. Dihexa's exceptional potency makes this principle more consequential here than it would be with a gentler compound. There is no shortcut that produces the same safety information.

Frequently Asked Questions

How much of each supplement should I take with Dihexa?

There are no dose numbers on this page, and that is intentional rather than an oversight. The right amount of choline, magnesium, vitamin D, and the other items on this list depends on your specific Dihexa protocol, your current bloodwork, and what you are already taking. Someone with confirmed low ferritin needs a meaningfully different iron approach than someone with normal stores. MyPeptidePal works out the specifics from your protocol, your labs, and your inputs, which is the only way to produce a number that is actually right for you rather than right for an average that does not describe anyone.

Which blood markers actually matter when running Dihexa?

Ferritin, homocysteine, 25-OH-D (vitamin D), and RBC magnesium are the four markers most directly connected to the supplements on this list. Beyond those, establishing a baseline for liver enzymes before starting is prudent, because Dihexa activates a pathway central to hepatic function and a pre-treatment reference point makes any changes meaningful. A baseline IGF-1 reading is also reasonable: Dihexa's downstream signaling shares territory with IGF-1-related pathways, and knowing where you started is the only way to interpret any changes that occur later. None of these require a specialist to order.

Do any of these supplements reduce how well Dihexa works?

None of the supplements on this list antagonize Dihexa's mechanism. The interactions worth concern involve prescription drugs, particularly c-Met inhibitors and the liver enzymes inhibitors that affect its clearance, not the nutritional stack described here. St. John's Wort is the one over-the-counter item that genuinely interferes because it activates the liver enzyme pathway that clears Dihexa, reducing the concentration available to do its work. Everything else in this guide either supports the synaptogenic process, mitigates its side effects, or closes a deficiency that would otherwise blunt the result.

Can I start everything on this list at the same time?

The start-low, one-at-a-time principle matters more with Dihexa than with most compounds because of its exceptional potency. Adding multiple new items simultaneously makes it impossible to attribute any effect, positive or adverse, to a specific cause. The sensible sequence is to address deficiencies first, particularly vitamin D, magnesium, B vitamins, and iron if ferritin is low, before introducing Dihexa, and then to add synergists one at a time with observation time between each. This is not excessive caution for its own sake. It is the only approach that builds an accurate picture of what your protocol is actually doing.

Do I need to keep taking these after stopping Dihexa?

The deficiency-correcting items on this list, B vitamins, vitamin D, magnesium, and iron where relevant, address genuine nutritional gaps that exist independently of Dihexa and have standalone value for neurological and general health. They are worth maintaining regardless of whether a Dihexa cycle is active. Whether to continue the synergists and choline between cycles is a more individual question. The structural synapses Dihexa helps form are real, and supporting them with adequate choline, DHA, and homocysteine control after a cycle is a reasonable argument for maintaining at least the foundational stack.

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world use of Dihexa and the nutrients that support it in one place.